Antiphospholipid antibodies are increasingly being identified as a cause of both arterial and
venous thrombosis as well as fetal wastage syndrome via placental vascular thrombosis …

Antiphospholipid antibodies are increasingly being identified as a cause of arterial and
venous thrombosis as well as fetal wastage syndrome via placental vascular thrombosis …

Antiphospholipid syndrome is an autoimmune disease which combines vascular thrombosis
and/or pregnancy complications with the presence of antiphospholipid antibodies. It could …

which include not only the lupus anticoagulant (LA) and anticardiolipin antibodies, but also
more recently recog-nized &dquo; subgroups&dquo; of antiphospholipid antibodies (anti …

The concept of the antiphospholipid syndrome (APS), comprising venous and arterial
thrombosis, recurrent fetal loss, and thrombocytopenia, has been expanded over the years …

The antiphospholipid syndrome (APS) is defined by the development of venous and/or
arterial thromboses, often multiple, and pregnancy morbidity (mainly, recurrent fetal losses) …

The antiphospholipid antibody syndrome (APS) is defined by the persistent presence of
antiphospholipid antibodies in patients with recurrent venous or arterial thromboembolism or …

The antiphospholipid antibody syndrome is a systemic, acquired, immune‐mediated
disorder characterized by episodes of venous, arterial, or microcirculation thrombosis and/or …

Antiphospholipid antibodies are strongly associated with thrombosis and appear to be the
most common of the acquired blood protein defects causing thrombosis. Based upon our …

The classical clinical picture of the antiphospholipid syndrome (APS) is characterized by
venous and arterial thromboses, fetal losses and thrombocytopenia, in the presence of …